Dr. Samip Master
Claim this profileLSU Health Sciences Center at Shreveport
Studies Plasma Cell Neoplasms
Studies Multiple Myeloma
5 reported clinical trials
13 drugs studied
Area of expertise
1Plasma Cell Neoplasms
Stage I
Stage II
Stage III
2Multiple Myeloma
Stage I
Stage II
Stage III
Affiliated Hospitals
Clinical Trials Samip Master is currently running
Combination Therapy
for Multiple Myeloma
This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as lenalidomide, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Daratumumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Anti-inflammatory drugs, such as dexamethasone lower the body's immune response and are used with other drugs in the treatment of some types of cancer. Adding bortezomib to daratumumab, lenalidomide, and dexamethasone may be more effective in shrinking the cancer or preventing it from returning, compared to continuing on daratumumab, lenalidomide, and dexamethasone.
Recruiting2 awards Phase 332 criteria
Nivolumab + Ipilimumab + Sargramostim
for Advanced Melanoma
This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable) and that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Colony-stimulating factors, such as sargramostim, may increase the production of white blood cells. It is not yet known whether nivolumab and ipilimumab are more effective with or without sargramostim in treating patients with melanoma.
Recruiting1 award Phase 2 & 323 criteria
More about Samip Master
Clinical Trial Related3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Samip Master has experience with
- Ipilimumab
- Nivolumab
- Lenalidomide
- Dexamethasone
- Sargramostim
- Daratumumab And Hyaluronidase-fihj
Breakdown of trials Samip Master has run
Plasma Cell Neoplasms
Multiple Myeloma
Cutaneous Melanoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Samip Master specialize in?
Samip Master focuses on Plasma Cell Neoplasms and Multiple Myeloma. In particular, much of their work with Plasma Cell Neoplasms has involved Stage I patients, or patients who are Stage II.
Is Samip Master currently recruiting for clinical trials?
Yes, Samip Master is currently recruiting for 3 clinical trials in Shreveport Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Samip Master has studied deeply?
Yes, Samip Master has studied treatments such as Ipilimumab, Nivolumab, Lenalidomide.
What is the best way to schedule an appointment with Samip Master?
Apply for one of the trials that Samip Master is conducting.
What is the office address of Samip Master?
The office of Samip Master is located at: LSU Health Sciences Center at Shreveport, Shreveport, Louisiana 71103 United States. This is the address for their practice at the LSU Health Sciences Center at Shreveport.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.